What is the evidence? In horses with septic bursitis for which the organism has not yet been identified, is IV regional perfusion with amikacin or cefotaxime likely to be effective?
Departments of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA. vfajt@cvm.tamu.edu
Virginia R
VR
Fajt
Angela M
AM
Van House
Clifford M
CM
Honnas
D000583:Amikacin / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001170:Arthritis, Infectious / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary*; D002062:Bursitis / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary*; D002439:Cefotaxime / Q000008:administration & dosage / Q000627:therapeutic use; D055317:Evidence-Based Practice; D005260:Female; D006734:Horse Diseases / Q000175:diagnosis / Q000188:drug therapy*; D006736:Horses; D007794:Lameness, Animal / Q000175:diagnosis*
D000900:Anti-Bacterial Agents; D000583:Amikacin; D002439:Cefotaxime